Vous avez cherché: stent (Anglais - Slovène)

stent thrombosis
tromboza stenta

acute stent thrombosis
akutna tromboza stenta

2,172 of these had a stent inserted during the study.
pri zdravljenju akutnega koronarnega sindroma brez elevacije spojnice st so zdravilo iscover primerjali s placebom (zdravilom brez zdravilne učinkovine) pri več kot 12. 000 bolnikih, zdravljenih do enega leta (študija cure), pri čemer je 2172 bolnikov med študijo imelo vstavljen stent.

there was also a reduction in the patients who had a stent inserted.
do zmanjšanja je prišlo tudi pri bolnikih, ki so imeli vstavljen stent.

for instructions for monitoring acute stent thrombosis, see section 4.4.
za navodila glede spremljanja akutne tromboze stenta glejte tudi poglavje 4.4.

you have a cardiac pacemaker or any ferromagnetic implant or a metallic stent in your body
imate srčni spodbujevalnik ali kakršen koli feromagnetni vsadek ali železno opornico v telesu,

two deaths occurred after acute stent thrombosis, 1 in each arm of the study.
po akutni trombozi sta se pojavili dva smrtna primera, vsak iz enega kraka študije.

during this procedure you may have a stent inserted in your blood vessel to help to keep it open.
med tem postopkom vam bodo morda v krvno žilo vstavili žilno opornico, ki bo žilo pomagala ohranjati odprto.

and this stent folds down using an origami pattern, based on a model called the water bomb base.
zloži se po vzorcu, ki uporablja ti. osnovo za vodno bombo.

coronary artery thrombosis and coronary stent thrombosis with myocardial infarction, and catheter thrombosis have each been reported rarely.
redko so poročali o trombozi koronarne arterije in trombozi z miokardnim infarktom, ter trombozi katetra.

for the treatment of this condition your doctor may have placed a stent in the blocked or narrowed artery to restore effective blood flow.
pri zdravljenju tega stanja vam je zdravnik v zamašeno ali zoženo arterijo morda moral vstaviti stent (žično opornico), da bi žilo tako razširil in obnovil pretok krvi.

prasugrel was associated with a 50% reduction in stent thrombosis through the 15 month follow-up period.
prasugrel je bil povezan s 50 % zmanjšanjem tromboze žilne opornice v 15 mesečnem obdobju spremljanja.

complications due to the underlying pancreatic cancer, especially biliary obstruction or presence of biliary stent, were identified as significant contributing factors.
zapleta zaradi osnovne bolezni, to je rak trebušne slinavke, ki so ju prepoznali kot pomembna dejavnika, ki prispevata k nastanku sepse, sta zlasti biliarna obstrukcija ali prisotnost biliarnega stenta.

a total of 17 deaths occurred after subacute stent thrombosis, 3 in the bivalirudin arm and 14 in the ufh plus gp iib/iiia arm.
po subakutni trombozi stenta je bilo skupaj 17 smrtnih žrtev, 3 iz kraka z bivalirudinom in 14 pri ufh in gp iib/iiia.

an additional retrospective analysis showed a nominally significant reduction in the incidence rates of stent thrombosis compared with placebo (see table 3).
dodatna retrospektivna analiza je pokazala nominalno pomembno zmanjšanje incidence tromboze stenta v primerjavi s placebom (glejte preglednico 3).

patients ≥ 75 years in whom the benefit with prasugrel was more evident included those with diabetes, stemi, higher risk of stent thrombosis, or recurrent events.
bolniki ≥ 75 let, pri katerih je bila korist zdravljenja s prasugrelom bolj očitna, so vključevali tiste z diabetesom, stemi, večjim tveganjem za trombozo žilne opornice ali ponovljenimi dogodki.

further detail regarding stent thrombosis is provided in section 4.8: the horizons trial (patients with stemi undergoing primary pci).
dodatne informacije glede tromboze stenta najdete v poglavju 4.8: preskušanje horizons (zdravljenja bolnikov s stemi, pri katerih je bila izvedena pci).

non-st segment elevation acute coronary syndrome (unstable angina or non-q-wave myocardial infarction), including patients undergoing a stent placement following percutaneous coronary intervention, in combination with acetylsalicylic acid (asa).
akutni koronarni sindrom brez elevacije st spojnice (nestabilna angina ali miokardni infarkt brez q zobca), vključno z bolniki, katerim je bil vstavljen stent po perkutani koronarni intervenciji, v kombinaciji z acetilsalicilno kislino (asa – acetylsalicylic acid).